Loading...
Chidamide induces apoptosis in DLBCL cells by suppressing the HDACs/STAT3/Bcl-2 pathway
Diffuse large B-cell lymphoma (DLBCL) is a highly heterogeneous malignant tumor type, and epigenetic modifications such as acetylation or deacetylation serve vital roles in its development. Chidamide, a novel histone deacetylase inhibitor, exerts an anticancer effect against various types of cancer....
Na minha lista:
| Udgivet i: | Mol Med Rep |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
D.A. Spandidos
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7974270/ https://ncbi.nlm.nih.gov/pubmed/33649847 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2021.11947 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|